PRME Stock

PRME Stock | On Friday, 9 May 2025 The Dow Jones Industrial Average (DJIA) opened -0.29 percent lower at 41249.38, compared to 41368.45 points at the previous Wall Street close.

On Friday, 9 May 2025 The S & P 500 index opened -0.07 percent lower at 5659.91 points, compared to 5663.94 points at the previous market close.

However, on Friday, 9 May 2025 New York-based tech-heavy Nasdaq Composite index opened 0.00 percent higher at 17928.92 points till 4.00 PM, compared to 17928.14 at the previous US market close.

The small-cap U.S. stock market Russell 2000 Index opened -0.17 percent lower at 2023.07, compared to 2026.41 points at the previous Wall Street close.

Saturday 10 May 2025 – PRME Stock Price

On Friday, 9 May 2025, the Prime Medicine, Inc. stock was in news and the counter opened at $1.33, dropped by -1.54 percent compared to the previous close. The stock price touched an intraday high of $1.49, while the intraday low was at $1.27. Prime Medicine, Inc. stock recorded a 52-week high of $8.27 and a 52-week low of $1.12. The trading volume was 1,377,854 stocks, while the average trading volume stood at 1,481,975 on Friday, 9 May 2025 till 4.00 PM.

According to the index, at time of writing (10.18 AM on Saturday 10 May 2025), Prime Medicine, Inc. (NASDAQ: PRME) market cap is $170.51M USD. However, on Friday the intraday trading range of PRME stock was $1.27 – $1.49. Prime Medicine, Inc.’s total debt as of Saturday 10 May 2025 is $144.359 Million USD.

Previous Close
1.32
Day’s Range
$1.27 – $1.49
Market Cap(Intraday)
170.682M
Earnings Date
May 8, 2025
Open
1.33
52 Week Range
1.1150 – 8.2700
Beta (5Yr Monthly)
1.90
Divident & Yield
Bid
1.2700 x 700
Volume
1,377,854
PE Ratio (TTM)
Ex-Dividend Date
Ask
1.3300 x 600
Avg. Volume
1.65M
EPS (TTM)
-1.6100
Analyst Average Target Est
12.00

Prime Medicine, Inc. Stock Technical Analysis

Prime Medicine, Inc. EMA and SMA

On Friday, 9 May 2025, SMA (Simple Moving Average) and EMA (Exponential Moving Average) over a short span of 5 days, SMA stands at -1.4, while the EMA is noted at -1.4.

Over 10 days, the SMA is -1.5, while the EMA is -1.5. The 20-day SMA stands at -1.5 compared to the EMA of -1.5.

For longer periods, the 50-day SMA is -1.7, and the 100-day SMA is -2.3, with the EMA at -2.3. However, the 200-day SMA is -3.1, with the EMA till 4.00 PM on Friday, 9 May 2025.

Prime Medicine, Inc. Key Resistance and Support Levels

The first key resistance is at 1.4 and first support is at 1.2. The second key resistance is at 1.6 and second support is at 1.1. However, the third key resistance is at 1.7 and third support is at 1.0.

Saturday 10 May 2025 – Return delivered by PRME Stock

Since today, Saturday 10 May 2025, over the last 1-year period PRME Stock price has delivered a negative return of -77.27% to investors.

However, on a Year-To-Date (YTD) basis, PRME Stock has delivered a negative return of -55.48% to investors.

Over the last 3-years and 5-years period from Saturday 10 May 2025, PRME Stock has respectively delivered a -93.15% and -93.15% return to investors.

YTD Return

-55.48%

1-Year Return

-77.27%

3-Year Return

-93.15%

5-Year Return

-93.15%

Forecaster – Wall Street Analyst Target and Estimates for Prime Medicine, Inc.

  • Out of the 12 analysts tracking this stock, 7 recommend Strong Buy.
  • Out of the 12 analysts tracking this stock, 4 recommend BUY.
  • Out of the 12 analysts tracking this stock, 1 recommend HOLD.

As of Saturday 10 May 2025, the average target price for Prime Medicine, Inc. is $12 with a high estimate of $18 and a low estimate is $6.

Prime Medicine, Inc.
JMP Securities
Current Stock Price
$1.3
Rating
Outperform
Target Price
$10
Upside
669.23%
Prime Medicine, Inc.
1.3000
-1.52%
Industry
Biotechnology
Beam Therapeutics Inc.
17.41
+0.93%
Industry
Biotechnology
Verve Therapeutics, Inc.
4.2300
-5.58%
Industry
Biotechnology
Caribou Biosciences, Inc.
0.7743
-1.99%
Industry
Biotechnology
Intellia Therapeutics, Inc.
8.12
-1.93%
Industry
Biotechnology
Sana Biotechnology, Inc.
1.8200
+0.55%
Industry
Biotechnology
Fate Therapeutics, Inc.
1.0400
+0.97%
Industry
Biotechnology
Metagenomi, Inc.
1.5100
-5.03%
Industry
Biotechnology
Editas Medicine, Inc.
1.4500
+4.32%
Industry
Biotechnology
Absci Corporation
2.7500
-1.79%
Industry
Biotechnology
Wave Life Sciences Ltd.
6.59
+0.69%
Industry
Biotechnology

FAQ’s

What is the PRME Stock price today?

As on Friday, 9 May 2025, PRME stock (NASDAQ: PRME) was trading at $1.3 till 4.00 PM.

What is PRME Stock prediction 2025?

As of Saturday 10 May 2025, the PRME Stock forecast says that average target price is $12 with a high estimate of $18 and a low estimate is $6.

What is PRME Stock PE ratio today on Saturday 10 May 2025?

The PE Ratio (TTM) of PRME stock is -0.78 today on Saturday 10 May 2025.

How much is Prime Medicine, Inc. Market cap today on Saturday 10 May 2025?

The PRME company Market cap reached 170.51M USD today on Saturday 10 May 2025.

Nasdaq Index Today on Saturday 10 May 2025?

On Friday, 9 May 2025 The Nasdaq Composite index opened 0.00 percent higher at 17928.92 points compared to the previous US market close.

Dow Jones Index today on Saturday 10 May 2025?

On Friday, 9 May 2025 The Dow Jones Industrial Average (DJIA) opened -0.29 percent lower at 41249.38 points compared to the previous US market close.